VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 89 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $57,000 | +9.6% | 5,000 | 0.0% | 0.01% | -7.1% |
| Q1 2020 | $52,000 | -36.6% | 5,000 | 0.0% | 0.01% | -22.2% |
| Q4 2019 | $82,000 | +24.2% | 5,000 | 0.0% | 0.02% | +20.0% |
| Q3 2019 | $66,000 | -5.7% | 5,000 | 0.0% | 0.02% | +15.4% |
| Q2 2019 | $70,000 | -23.9% | 5,000 | 0.0% | 0.01% | -18.8% |
| Q1 2019 | $92,000 | -29.8% | 5,000 | 0.0% | 0.02% | -36.0% |
| Q4 2018 | $131,000 | +13.9% | 5,000 | 0.0% | 0.02% | +31.6% |
| Q3 2018 | $115,000 | +21.1% | 5,000 | 0.0% | 0.02% | +11.8% |
| Q2 2018 | $95,000 | +13.1% | 5,000 | 0.0% | 0.02% | +6.2% |
| Q1 2018 | $84,000 | +10.5% | 5,000 | 0.0% | 0.02% | +23.1% |
| Q4 2017 | $76,000 | -15.6% | 5,000 | 0.0% | 0.01% | -18.8% |
| Q3 2017 | $90,000 | +9.8% | 5,000 | 0.0% | 0.02% | +6.7% |
| Q2 2017 | $82,000 | -41.4% | 5,000 | -50.0% | 0.02% | -40.0% |
| Q1 2017 | $140,000 | -12.5% | 10,000 | 0.0% | 0.02% | -34.2% |
| Q4 2016 | $160,000 | -3.6% | 10,000 | 0.0% | 0.04% | -15.6% |
| Q3 2016 | $166,000 | +48.2% | 10,000 | 0.0% | 0.04% | +40.6% |
| Q2 2016 | $112,000 | +33.3% | 10,000 | 0.0% | 0.03% | +6.7% |
| Q1 2016 | $84,000 | -9.7% | 10,000 | 0.0% | 0.03% | -18.9% |
| Q4 2015 | $93,000 | -17.7% | 10,000 | 0.0% | 0.04% | -22.9% |
| Q3 2015 | $113,000 | -11.0% | 10,000 | 0.0% | 0.05% | +4.3% |
| Q2 2015 | $127,000 | +36.6% | 10,000 | 0.0% | 0.05% | +27.8% |
| Q1 2015 | $93,000 | -35.0% | 10,000 | 0.0% | 0.04% | -41.9% |
| Q4 2014 | $143,000 | +37.5% | 10,000 | 0.0% | 0.06% | +21.6% |
| Q3 2014 | $104,000 | -35.8% | 10,000 | 0.0% | 0.05% | -34.6% |
| Q2 2014 | $162,000 | -0.6% | 10,000 | 0.0% | 0.08% | -19.6% |
| Q1 2014 | $163,000 | +31.5% | 10,000 | 0.0% | 0.10% | +32.9% |
| Q4 2013 | $124,000 | +12.7% | 10,000 | 0.0% | 0.07% | +2.8% |
| Q3 2013 | $110,000 | +37.5% | 10,000 | 0.0% | 0.07% | +20.3% |
| Q2 2013 | $80,000 | – | 10,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |